Fibroadenoma epidemiology and demographics

Fibroadenoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fibroadenoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT Scan
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fibroadenoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fibroadenoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fibroadenoma epidemiology and demographics
CDC on Fibroadenoma epidemiology and demographics
Fibroadenoma epidemiology and demographics in the news
Blogs on Fibroadenoma epidemiology and demographics
Directions to Hospitals Treating Fibroadenoma
Risk calculators and risk factors for Fibroadenoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Epidemiology and Demographics

Prevelance

• Fibroadenoma is the most common breast mass among adolescent women in the United States.

Age

• Fibroadenoma commonly affects individuals younger than 30 years of age.